It uses a combination of radiologic findings, p53 positivity, and Ki-67 index to stratify tumors into five clinicopathologic “grades” which range from non-invasive tumors with low Ki-67 labeling (grade 1a) to metastatic tumors (grade 3). The gene discussed is MKI67; the disease is metastatic neoplasm.